SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-005979
Filing Date
2013-05-14
Accepted
2013-05-14 16:44:36
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q unigene_10q-033113.htm 10-Q 739766
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 14591
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 14717
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 8343
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 8877
  Complete submission text file 0001437749-13-005979.txt   6204698

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE ugne-20130331.xml EX-101.INS 879181
7 XBRL TAXONOMY EXTENSION SCHEMA ugne-20130331.xsd EX-101.SCH 64069
8 XBRL TAXONOMY EXTENSION CALCULATION ugne-20130331_cal.xml EX-101.CAL 25446
9 XBRL TAXONOMY EXTENSION DEFINITION ugne-20130331_def.xml EX-101.DEF 359030
10 XBRL TAXONOMY EXTENSION LABELS ugne-20130331_lab.xml EX-101.LAB 432929
11 XBRL TAXONOMY EXTENSION PRESENTATION ugne-20130331_pre.xml EX-101.PRE 349450
Mailing Address 81 FULTON STREET BOONTON NJ 07005
Business Address 81 FULTON STREET BOONTON NJ 07005 973-265-1100
UNIGENE LABORATORIES INC (Filer) CIK: 0000352747 (see all company filings)

IRS No.: 222328609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16005 | Film No.: 13842188
SIC: 2833 Medicinal Chemicals & Botanical Products